SaverOne Announces New Deployment of Its Driver Distraction Prevention System in Teva Pharmaceutical’s Truck Fleet

Rhea-AI Summary

SaverOne (Nasdaq: SVRE) has secured a contract with Teva Pharmaceutical Industries to install its Driver Distraction Prevention System across Teva's entire fleet of 50 pharmaceutical delivery trucks in Israel. This expansion follows a successful initial deployment in 14 trucks.

Teva, a global pharmaceutical leader and one of the world's largest generic drug manufacturers, operates fleets across more than 60 countries. The company's Traffic Safety Officer, Ronen Talmor, emphasized Teva's commitment to safety and highlighted SaverOne's system as a important tool in preventing road accidents caused by driver distraction.

SaverOne's CEO, Ori Gilboa, expressed optimism about potential future deployments across Teva's global fleet operations, noting growing demand for their technology in commercial fleet safety solutions.

Positive

• Contract expansion from 14 to 50 trucks with major pharmaceutical company
• Potential for international expansion across Teva's operations in 60+ countries
• Validation of technology by global industry leader

Negative

• initial deployment size of 50 trucks

Insights

Fleet Technology Analyst

The new contract with Teva Pharmaceutical marks a pivotal milestone for SaverOne, establishing a strong foothold in the pharmaceutical logistics sector. The expansion from 14 to 50 trucks demonstrates clear product validation and successful pilot-to-full deployment conversion. While the immediate revenue impact from this deployment may be modest given SaverOne's market cap, the strategic value is substantial.

The pharmaceutical delivery fleet market presents unique opportunities due to strict safety regulations and high-value cargo transportation. Teva's global fleet operations across 60+ countries create a significant expansion runway, potentially serving as a reference customer for other pharmaceutical companies. The industry's emphasis on risk mitigation and safety compliance aligns perfectly with SaverOne's value proposition.

The endorsement from Teva's Traffic Safety Officer is particularly noteworthy as it positions SaverOne's system as an essential component of comprehensive safety programs, rather than just an optional add-on. This perception shift could accelerate adoption across the broader commercial fleet market, where safety technology investments are increasingly viewed as strategic rather than discretionary.

For investors, this deployment showcases three critical elements: 1) Product-market fit in a demanding enterprise environment 2) Scalability potential within global organizations 3) Strong validation from a tier-1 pharmaceutical company. The successful conversion from pilot to full fleet deployment also indicates favorable unit economics and customer satisfaction, key metrics for B2B SaaS solutions in the fleet management space.

Teva, a global pharmaceutical leader, to install the SaverOne System across its entire fleet of 50 delivery trucks in Israel

Petah Tikvah, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a leading innovator in transportation safety technology, today announced the award of a new contract with Teva Pharmaceutical Industries Ltd. (Teva), to install the SaverOne System across its entire fleet of 50 pharmaceutical delivery trucks. This follows the successful initial deployment in 14 trucks.

Headquartered in Israel, Teva is a multinational pharmaceutical company and one of the world’s largest generic drug manufacturers. Teva operates a global fleet supporting its supply chain across more than 60 countries.

Mr. Ori Gilboa, CEO of SaverOne commented, “We are proud of this new collabortion with Teva, a global pharmaceutical leader, in supporting the safety of their drivers and deliveries.  While we look forward to successfully completing the installation in Israel across all 50 of their trucks, we believe there is strong future potential for further deployments in other countries within Teva’s global fleets and operations. This win underscores continued growing demand for our technology and highlights our ability to deliver effective solutions that help prevent driver distractions in commercial fleets.”

Mr. Ronen Talmor, Traffic Safety Officer at Teva, commented, “As a company that places safety as a top priority, whether workplace safety or road safety, we invest significant time and money in technological solutions and training to prevent accidents. When we discovered SaverOne’s system, which essentially complements our efforts as a company to prevent road accidents and eliminate the number one cause of such accidents - driver distraction, we immediately recognized its value. I believe that any company that, like us, prioritizes safety will not overlook this highly significant system.”

About the SaverOne System

SaverOne's system is installed in vehicles to solve the problem of driver distraction, as a result of drivers using distracting applications on their mobile phones while driving in a way that endangers their safety and the safety of their passengers. This phenomenon is considered one of the leading causes of global road accidents. According to the US National Highway Traffic Safety Administration, the annual cost of road accidents just in the United States stands at about $870 billion each year, excluding the costs of serious injury or death, with a quarter of those accidents estimated to be related to the use of the mobile phones while driving. SaverOne's technology specifically recognizes the driver area in the vehicle. It prevents the driver from accessing distracting applications such as messaging while allowing others (navigation as an example) without user intervention or consent, creating a safer driving environment.

SaverOne's primary target markets include commercial and private vehicle fleets interested in reducing potential damages and significant costs, vehicle manufacturers interested in integrating safety solutions into their vehicles, and insurance and leasing companies. SaverOne initially addresses car fleets with a focus on the Israeli, European, and US markets and other markets worldwide. SaverOne believes that an increased focus on monitoring and prevention of cellular distraction systems in vehicles, driven by upcoming expected EU regulation, will likely have a dramatic positive impact on the demand for its systems in the future.

The Company's strategy is to provide its technology to customers in the aftermarket and address OEM vehicle manufacturers to integrate the Company's protection technologies during the vehicle manufacturing process.  

About SaverOne

SaverOne is a technology company that designs, develops, and commercializes OEM and aftermarket solutions and technologies to lower the risk of and prevent vehicle accidents. 

SaverOne's initial product line is a suite of solutions that saves lives by preventing car accidents resulting from distraction from using mobile phones while driving. SaverOne is also developing a sensor system for early location and direction detection under all visibility conditions of vulnerable road users (VRU) through their cellphone footprint.

Learn more at https://saver.one/

Forward Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws that are subject to substantial risks and uncertainties. All statements, besides those of historical fact, contained in this press release are forward-looking. Forward-looking statements contained in this press release include but are not limited to, statements regarding SaverOne's strategic and business plans, technology, relationships, objectives, and expectations for its business, the impact of trends on and interest in its business, intellectual property or product and its future results, operations, and financial performance and condition and may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will" "would," or the negative of these words or other similar expressions. However, not all forward-looking statements contain these words. Forward-looking statements are based on SaverOne's current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions about future events that may not prove accurate. Many factors could cause SaverOne's actual activities or results to differ materially from those anticipated in such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: the ability of our technology to substantially improve the safety of drivers; SaverOne’s planned level of revenues and capital expenditures and its ability to continue as a going concern; SaverOne’s ability to maintain its listing on the Nasdaq Capital Market; the ability of SaverOne’s technology to substantially improve the safety of drivers; SaverOne’s ability to broaden the footprint of its product and services within Teva globally and to market and sell its products generally; SaverOne’s plans to continue to invest in research and development to develop technology for both existing and new products; SaverOne’s intention to advance its technologies and commercialization efforts; SaverOne’s plan to seek patent, trademark and other intellectual property rights for products and technologies in the United States and internationally, as well as its ability to maintain and protect the validity of currently held intellectual property rights; SaverOne’s expectations regarding future changes in its cost of revenues and operating expenses; interpretations of current laws and the passage of future laws; acceptance of its business model by investors; the ability to correctly identify and enter new markets; the impact of competition and new technologies; general market, political and economic conditions in the countries in which SaverOne operates; projected capital expenditures and liquidity; SaverOne’s intention to retain key employees, and its belief that it will maintain good relations with all employees; a resurgence of the COVID-19 pandemic and its impact on business and industry; as well as other risks and uncertainties, including, but not limited to, the risks detailed in the Company's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the "SEC") on March 25, 2024  and in subsequent filings with the SEC. Forward-looking statements in this announcement are made as of this date, and SaverOne undertakes no duty to update such information except as required under applicable law.

International Investor Relations Contact: Ehud Helft +1 212 378 8040 saverone@ekgir.com

FAQ

How many trucks will implement SaverOne's (SVRE) system in Teva's Israeli fleet?

SaverOne will install its Driver Distraction Prevention System across Teva's entire fleet of 50 pharmaceutical delivery trucks in Israel.

What is the expansion potential for SaverOne (SVRE) within Teva's global operations?

There is potential for expansion across Teva's operations in more than 60 countries where they maintain delivery fleets.

How many trucks were in SaverOne's (SVRE) initial deployment with Teva?

The initial deployment included 14 trucks before expanding to the entire fleet of 50 trucks.

What was Teva's reason for choosing SaverOne's (SVRE) system?

Teva chose SaverOne's system to prevent road accidents by addressing driver distraction, which they identified as the primary cause of accidents.